Title: A Comparative Study to Assess the Effectivenesss of Nebulised 3% Hypertonic Saline, 0.9% Normal Saline and Salbutalmol in Management of Acute Bronchiolitis

Authors: Rakesh Ranjan Kumar, Rizwan Ahmar

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i5.204

Abstract

Aims And Objectives: Bronchiolitis is the most common lower respiratory tract infection among infants in both developed and developing countries. Study aim is to compare the effects of nebulized 3% hypertonic saline, 0.9% saline and Salbutamol in acute bronchiolitis. 

Material and Methods: 60 Children of age 1 month to 24 months with clinical diagnosis of acute bronchiolitis were included in the study. Cases were divided into 3 groups randomly –  3% hypertonic saline (HS) as Group A, 0.9% normal saline as Group B and Salbutamol as Group C. Four doses of nebulization at an interval of six hours were given daily to patient of each group till discharge.

Results: Baseline Clinical Severity (CS) scores in 3%HS, 0.9% Normal Saline and Salbutamol groups were 6 ±1, 5.8±1.5 and 5.5±2.5 respectively (p=0.14), which after treatment dropped to 1.0±0.2, 3.19±0.8 and 1.65±0.7 respectively on the 4th day of treatment (p<0.01). Length of hospital stay in 3% HS, 0.9% Normal Saline and Salbutamol groups was 3.0±1.5, 5.0±1.2 and 3.5±1.7 days respectively, which was found to be statistically significant (p= 0.001).

Conclusion: 3% Hypertonic Saline nebulization (without additional bronchodilator) significantly reduces the CS scores and length of hospital stay as compared to 0.9% Normal Saline and Salbutamol nebulization.

Keywords:  Bronchiolitis, management, 3 % hypertonic saline nebulization.

References

1.      Klassen TP. Recent advances in the treatment of bronchiolitis and laryngitis. Pediatr Clin   North Am   1997; 44:249-61.

2.      Ray MS, Singh V. Comparison of nebulized adrenaline versus Salbutamol in Wheeze associated respiratory tract infection in infants. Indian  Pediatric 2002; 39:12-22.

3.      Dennis MM. Bronchiolitis. Arch Dis Child Educ Pract 2005; 90:81-6.

4.      Panitch HB, Callahan CW Jr, Schidlow DV. Bronchiolitis in  children.  Clin Chest  Med   1993;14:715-31.

5.      Kimberly DW, Goodman DM. Wheezing, bronchiolitis and  bronchitis. In: Kliegman R M, Behram RE, Jenson HB, Stanton BF editors.  Nelson  Text Book of Pediatrics. 18th ed.  New    Delhi: Elsevier;  2007. p.  1774.

6.      Handforth J, Friedland JS, Sharland M. Basic epidemiology and immunopathology  of RSV  in  children. Paediatr Respir Rev 2000;1:210-4.

7.      Wang EE, Milner RA, Navas L, Maj H. Observer agreement for respiratory signs  and   oximetry  in infants hospitalized with lower respiratory infections. Am Rev Respi  Dis    1992;145:106-9

8.      Mandelberg A, Amirav I. Hypertonic Saline or High Volume Normal Saline for Viral  bronchiolitis.   Pediatric Pulmon. 2010;  45: 36-40.

9.      Sarrell EM, Tal G, Witzling M, Someck E, Houri S,et al.Nebulized  3% hypertonic  saline solution    treatment  in ambulatory children with viral bronchiolitis decreases symptoms.Chest 2002;122: 2015-20.

10.  Mandelberg A, Tal G, Witzling M, Someck E,  et al.  Nebulized 3%   hypertonic  saline solution treatment in hospitalized infants with viral bronchiolitis. Chest 2003; 123:481-7

11.  Kuzik BA, Al Qadhi SA, Kent S, Flavin MP, et al  Nebulized  hypertonic saline in the treatment of viral bronchiolitis in infants. J  Pediatr. 2007; 151(3): 266-70.

12.  Luo Z, Liu E, Luo J, Li S,  et al. Nebulized hypertonic  saline/ Salbutamol solution treatment in hospitalized children with  mild to moderate bronchiolitis. Pediatr  Int 2010; 52: 199-202.

Corresponding Author

Rakesh Ranjan Kumar

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.